Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related NVO
Conquering Hemophilia: Novo Nordisk Reports Encouraging Data From Phase III Trial Of NovoEight
5 NYSE Healthcare Stocks With The Highest ROE
No Letting Up In Pharma As First-Half Gains Outweigh Losses (Seeking Alpha)
Related CZR
Downtown Las Vegas Continues To Outperform The Strip In 2015
Jim Cramer Advises His Viewers On GlaxoSmithKline, American International Group, Caesars And Caesars Acquisition

Novo Nordisk A/S (NYSE: NVO) shares dropped 13.43% to $166.36 in pre-market trading. Novo Nordisk shares have surged 40.27% over the past 52 weeks, while the S&P 500 index has gained 12.29% in the same period.

Caesars Entertainment (NASDAQ: CZR) dipped 7.12% to $12.92 in the pre-market session. Caesars Entertainment's trailing-twelve-month ROE is -179.12%.

BlackBerry (NASDAQ: BBRY) shares fell 4.06% to $15.82 in the pre-market trading. Bed BlackBerry's trailing-twelve-month profit margin is -6.90%.

Sarepta Therapeutics (NASDAQ: SRPT) dipped 3.15% to $28 in the pre-market session. Sarepta's PEG ratio is -0.51.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (CZR + BBRY)

Around the Web, We're Loving...

Get Benzinga's Newsletters